Valuation: Terumo Corporation

Market Cap 3,375B 21.42B 18.55B 17.29B 15.9B 30.03B 2,037B 30.36B 203B 79.76B 1,019B 80.45B 78.67B P/E 2027 *
19.9x
P/E 2028 * 17.8x
Enterprise Value 3,435B 21.8B 18.88B 17.6B 16.19B 30.56B 2,073B 30.91B 207B 81.19B 1,037B 81.89B 80.08B EV / Sales 2027 *
2.75x
EV / Sales 2028 * 2.52x
Free-Float
97.07%
Yield 2027 *
1.58%
Yield 2028 * 1.76%
1 day+0.94%
1 week-4.39%
Current month-0.62%
1 month+0.70%
3 months+18.01%
6 months+12.93%
Current year+1.74%
1 week 2,253
Extreme 2253
2,350
1 month 2,133
Extreme 2133
2,459
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%-4.39%-9.82%+3.87% 21.42B
+0.24%-2.12%-19.11%-1.80% 183B
-0.24%-1.77%-4.10%+2.32% 110B
+3.57%-0.44%+8.51%+71.16% 61.72B
-2.39%+6.06%+35.36%+51.32% 54.98B
+0.32%+1.34%-3.52%-36.98% 47.02B
-12.79%-8.52% - - 32.16B
-4.92%+10.01%+9.54%-31.31% 31.19B
+0.65%+4.02%+46.96%-6.41% 24.7B
-0.06%-0.90%+3.95%+2.96% 22.68B
Average -1.47%+0.86%+7.53%+6.13% 58.89B
Weighted average by Cap. -0.69%+0.04%-0.55%+7.93%

Financials

2027 *2028 *
Net sales 1,249B 7.93B 6.87B 6.4B 5.89B 11.12B 754B 11.24B 75.23B 29.53B 377B 29.78B 29.13B 1,329B 8.44B 7.31B 6.81B 6.27B 11.83B 802B 11.96B 80.05B 31.42B 401B 31.69B 30.99B
Net income 169B 1.07B 931M 868M 798M 1.51B 102B 1.52B 10.2B 4B 51.13B 4.04B 3.95B 189B 1.2B 1.04B 970M 892M 1.68B 114B 1.7B 11.4B 4.47B 57.15B 4.51B 4.41B
Net Debt 60.46B 384M 332M 310M 285M 538M 36.48B 544M 3.64B 1.43B 18.25B 1.44B 1.41B -22.97B -146M -126M -118M -108M -204M -13.86B -207M -1.38B -543M -6.94B -548M -536M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
06/08/26 ¥2,308.50 +0.90% 2,256,000
05/08/26 ¥2,288.00 -1.51% 4,036,400
04/08/26 ¥2,323.00 +0.50% 2,875,800
03/08/26 ¥2,311.50 -0.54% 3,619,300
31/07/26 ¥2,324.00 -3.79% 5,158,600
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,288.00JPY
Average target price
3,048.46JPY
Spread / Average Target
+33.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock